Adenoviral vectors--how to use them in cancer gene therapy?

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies beyond conventional treatments.
• Gene therapy, initially developed for monogenic disorders, is emerging as a promising approach for cancer treatment.
• Adenoviruses are frequently utilized as vectors in cancer gene therapy due to their versatility.

Purpose of the Study:

• To review the molecular biology of adenoviruses and the principles of constructing adenoviral vectors for gene therapy.
• To explore the application of cancer gene therapy concepts, including in vitro and in vivo studies.
• To highlight the significance of retargeting adenoviruses for enhanced specificity in cancer gene therapy.

Main Methods:

• Detailed review of adenovirus molecular biology and adenoviral vector construction.
• Analysis of in vitro and in vivo applications of gene therapy strategies for cancer.
• Exploration of adenovirus retargeting techniques to achieve tumor-specific transgene expression.

Main Results:

• Adenoviruses serve as effective vectors for gene therapy, with established methods for vector construction.
• Cancer gene therapy strategies, utilizing adenoviral vectors, have demonstrated potential in both laboratory and clinical settings.
• Retargeting adenoviruses leverages tumor-specific characteristics to restrict gene expression to malignant tissues.

Conclusions:

• Adenoviral vectors are a key component in the development of innovative cancer gene therapies.
• Retargeting adenoviruses represents a significant advancement, improving the precision and safety of gene therapy for cancer.
• This approach offers a novel pathway for cancer treatment by exploiting tumor microenvironment features for targeted gene delivery.